State Street’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

State Street’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-181,527	Closed	-$4.43M	–	3820
2017 Q4	$4.43M	Buy	181,527 +24,762	+16%	+$476K	﹤0.01%	2844
2017 Q3	$2.9M	Buy	156,765 +15,909	+11%	+$276K	﹤0.01%	3045
2017 Q2	$2.33M	Buy	140,856 +29,386	+26%	+$409K	﹤0.01%	3065
2017 Q1	$1.54M	Buy	111,470 +5,687	+5%	+$91.3K	﹤0.01%	3174
2016 Q4	$2.01M	Buy	105,783 +8,251	+8%	+$158K	﹤0.01%	3100
2016 Q3	$2.16M	Buy	97,532 +1,492	+2%	+$28K	﹤0.01%	2942
2016 Q2	$1.75M	Buy	96,040 +45,267	+89%	+$779K	﹤0.01%	3084
2016 Q1	$923K	Buy	50,773 +3,714	+8%	+$60.1K	﹤0.01%	3238
2015 Q4	$791K	Buy	47,059 +2,132	+5%	+$36.2K	﹤0.01%	3259
2015 Q3	$811K	Buy	44,927 +251	+0.6%	+$5.59K	﹤0.01%	3249
2015 Q2	$1.16M	Buy	+44,676	New	+$1.13M	﹤0.01%	3206

State Street's ENTL Position: Q1 2018 in Review

State Street sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 181,527 shares — an estimated $4.43M sold.

State Street first reported a position in ENTL in Q2 2015 and held it in 11 quarters. The position peaked at $4.43M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

State Street reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
State Street sold 181,527 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $4.43M.
State Street first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
State Street's Entellus Medical, Inc. Common Stock position peaked at $4.43M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on State Street's 13F filing for Q1 2018, filed 15 May 2018.